Alex Gordon
Alex Gordon
The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing [0.03%]
2002年《儿童最佳药品法》：自愿激励机制的兴起及国会拒绝要求进行儿科试验
Lauren Hammer Breslow
Lauren Hammer Breslow
On January 4, 2002, President Bush signed into law the Best Pharmaceuticals for Children Act, which is the government's most comprehensive legislation regarding pediatric research to date. The Act offers pharmaceutical companies a six-month...
Patrick J Kennedy
Patrick J Kennedy
In this Policy Essay, Representative Patrick Kennedy argues that insurance discrimination against those suffering from mental illness constitutes a serious and often overlooked deficiency of the modern American health care system. While the...
The case for regulating collaborative reproduction: a children's rights perspective [0.03%]
关于协作生育监管的儿童权利视角的观点
Helen M Alvare
Helen M Alvare
There is little regulation of collaborative reproduction--the use of the eggs, sperm, or embryos of a third party to create a child biologically unrelated to at least one intending parent. This Article argues that the dearth of regulation s...
Mental health legislation and its relationship to program development: an international review [0.03%]
心理健康立法与项目开发的关系：国际综述
Timothy W Harding,William J Curran
Timothy W Harding
Beyond the "cuckoo's nest": a proposal for federal regulation of psychosurgery [0.03%]
走出"钟楼怪人"的世界：有关政府规范精神外科手术的建议
Steve Knowles
Steve Knowles
Informed and substitute consent to health care procedures: a proposal for state legislation [0.03%]
关于医疗程序的知情同意和替代同意的立法建议
Susan K Gauvey, et al.
Susan K Gauvey
Jennifer Cannon,Michelle Haas
Jennifer Cannon
Charles H Baron,Clyde Bergstresser,Dan W Brock et al.
Charles H Baron et al.
Medicare's End-Stage Renal Disease Program: its development and implications for health care policy [0.03%]
美国医疗照顾制度的末期肾病计划及其对医疗卫生政策的影响分析
H Bradley Southern
H Bradley Southern